Maintenance of the CD40-related immunodeficient response in hyper-IgM B cells immortalized with a LMP1-regulated mini-EBV

Journal of Leukocyte Biology

Volumn 78, Issue 3, 2005, Pages 620-629

  Lu, Kristina T ^a   Dryer, Rebecca L ^a   Song, Charles ^b   Covey, Lori R ^a,c  

^a RUTGERS UNIVERSITY   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

B cell activation; B cell proliferation; Lymphoblastoid; Signal transduction; Viral transformation

Indexed keywords

CD23 ANTIGEN; CD38 ANTIGEN; CD40 ANTIGEN; LATENT MEMBRANE PROTEIN 1; VIRUS PROTEIN;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CELL IMMORTALIZATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENETIC RECOMBINATION; GENETIC TRANSCRIPTION; GERM LINE; HUMAN; HUMAN CELL; HYPERIMMUNOGLOBULINEMIA M; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOREGULATION; IN VITRO STUDY; LYMPHOBLASTOID CELL; MITOGENESIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANTIGENS, CD38; ANTIGENS, CD40; B-LYMPHOCYTES; CELL LINE, TRANSFORMED; HUMANS; IMMUNOGLOBULIN M; IMMUNOLOGIC DEFICIENCY SYNDROMES; PHENOTYPE; RECEPTORS, IGE; SIGNAL TRANSDUCTION; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4;

EID: 24744449953     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0305159     Document Type: Article

References (67)

1. Notarangelo, L. D., Duse, M., Ugazio, A. G. (1992) Immunodeficiency with hyper-IgM (HIM). Immunodefic. Rev. 3, 101-122.
2. Levy, J., Espanol-Boren, T., Thomas, C., Fischer, A., Tovo, P., Bordigoni, P., Resnick, I., Fasth, A., Baer, M., Gomez, L., Sanders, E. A., Tabone, M. D., Plantaz, D., Etzioni, A., Monafo, V., Abinun, M., Hammarstrom, L., Abrahamsen, T., Jones, A., Finn, A., Klemola, T., DeVries, E., Sanal, O., Peitsch, M. C., Notarangelo, L. D. (1997) Clinical spectrum of X-linked hyper-IgM syndrome. J. Pediatr. 131, 47-54.
3. Aruffo, A., Farrington, M., Hollenbaugh, D., Li, X., Milatovich, A., Nonoyama, S., Bajorath, J., Grosmaire, L. S., Stenkamp, R., Neubauer, M., Roberts, R. L. Noelle, R. J., Ledbetter, J. A., Fraucke, U., Ochs, H. D. (1998) The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked immunodeficiency with hyper-IgM. Cell 72, 291-300.
4. Korthauer, U., Graf, P., Mages, H. W., Briere, F., Padayachce, M., Malcolm, S., Ugazio, A. G., Notarangelo, L. D., Levinsky, R. J., Kroezek, R. A. (1993) Defective expression of T-cell CD40 liqand causes X-linked immunodeficiency with hyper-IgM. Nature 361, 539-541.
5. DiSanto, J. P., Bonnefoy, J. Y., Gauchat, J. F., Fischer, A., de SaintBasile, G. (1993) CD40 ligand mutations in X-linked immunodeficiecy with hyper-IgM. Nature 361, 541-543.
6. Allen, R. C., Armitage, R. J., Conley, M. E., Rosenblatt, H., Jenkins, N. A., Copeland, N. G., Bedell, M. A., Edelhoff, S., Disteche, C. M., Simoneaux, D. K., Fanslow, W. C., Belmont, J., Spriggs, M. K. (1993) CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259, 990-993.
7. Fuleihan, R., Ramesh, N., Loh, R., Jabara, H., Rosen, R. S., Chatila, T., Fu, S. M., Stamenkovic, I., Geha, R. S. (1993) Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc. Natl. Acad. Sci. USA 90, 2170-2173.
8. Durandy, A., Schiff, C., Bonnefoy, J. Y., Forveille, M., Rousset, F., Mazzei, G., Milili, M., Fischer, A. (1993) Induction by anti-CD40 antibody or soluble CD40 ligand and cytokines of IgG, IgA, and IgE production by B cells from patients with X-linked hyper IgM syndrome. Eur. J. Immunol. 23, 2294-2299.
9. Banchereau, J., Bazan, F., Blanchard, D., Briere, F., Galizzi, J. P., van Kooten, C., Liu, Y. J., Rousset, F., Saeland, S. (1994) The CD40 antigen and its ligand. Ann. Rev. Immunol. 12, 881-922.
10. Clark, L. B., Foy, T. M., Noelle, R. J. (1996) CD40 and its ligand. Adv. Immunol. 63, 43-78.
11. Etzioni, A., Ochs, H. D. (2004) The hyper IgM syndrome-an evolving story. Pediatr. Res. 56, 519-525.
12. Revy, P., Muto, T., Levy, Y., Geissmann, F., Plebani, A., Sanal, O., Catalan, N., Forveille, M., Dufoureq-Labelouse, R., Gennery, A., Tezcan, I., Ersoy, F., Kayserili, H., Ugazio, A. G., Brousse, N., Muramatsu, M., Notarangelo, L. D., Kinoshita, K., Honjo, T., Fischer, A., Durandy, A. (2000) Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102, 565-575.
13. Muramatsu, M., Sankaranand, V. S., Anant, S., Sugai, M., Kinoshita, K., Davidson, N. O., Honjo, T. (1999) Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J. Biol. Chem. 274, 18470-18476.
14. Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y., Honjo, T. (2000) Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102, 553-563.
15. Ferrari, S., Giliani, S., Insalaco, A., Al-Ghonaium, A., Soresina, A. R., Loubser, M., Avanzini, M. A., Marconi, M., Badolato, R., Ugazio, A. G., Levy, Y., Catalan, N., Durandy, A., Tbakhi, A., Notarangelo, L. D., Plebani, A. (2001) Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc. Natl. Acad. Sci. USA 98, 12614-12619.
16. Zonana, J., Elder, M. E., Schneider, L. C., Orlow, S. J., Moss, C., Golabi, M., Shapira, S. K., Farndon, P. A., Wara, D. W., Emmal, S. A., Ferguson, B. M. (2000) A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-γ (NEMO). Am. J. Hum. Genet. 67, 1555-1562.
17. Doffinger, R., Smahi, A., Bessia, C., Geissmann, F., Feinberg, J., Durandy, A., Bodemer, C., Kenwrick, S., Dupnis-Girod, S., Blanche, S., Wood, P., Rabia, S. H., Headon, D. J., Overbeek, P. A., Le Deist, F., Holland, S. M., Belani, K., Kumararatne, D. S., Fischer, A., Shapiro, R., Conley, M. E., Reimund, E., Kalhoff, H., Abinun, M., Munnich, A., Israel, A., Courtois, G., Casanova, J. L. (2001) X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-κB signaling. Nat. Genet. 27, 277-285.
18. Jain, A., Ma, C. A., Liu, S., Brown, M., Cohen, J., Strober, W. (2001) Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat. Immunol. 2, 223-228.
19. Bhushan, A., Barnhart, B., Shone, S., Song, C., Covey, L. R. (2000) A transcriptional defect underlies B lymphocyte dysfunction in a patient diagnosed with non-X-linked hyper-IgM syndrome. J. Immunol. 164, 2871-2880.
20. Kintner, C., Sugden, B. (1981) Identification of antigenic determinants unique to the surfaces of cells transformed by Epstein-Barr virus. Nature 294, 458-460.
21. Thorley-Lawson, D. A., Mann, K. P. (1985) Early events in Epstein-Barr virus infection provide a model for B cell activation. J. Exp. Med. 162, 45-59.
22. Thorley-Lawson, D. A., Nadler, L. M., Bhan, A. K., Schooley, R. T. (1985) BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus. J. Immunol. 134, 3007-3012.
23. Calender, A., Billaud, M., Aubry, J. P., Banchereau, J., Vuillaume, M., Lenoir, G. M. (1987) Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. Proc. Natl. Acad. Sci. USA 84, 8060-8064.
24. Patarroyo, M., Clark, E. A., Prieto, J., Kantor, C., Gahmberg, C. G. (1987) Identification of a novel adhesion molecule in human leukocytes by monoclonal antibody LB-2. FEBS Lett. 210, 127-131.
25. Rothlein, R., Dustin, M. L., Marlin, S. D., Springer, T. A. (1986) A human intercellular adhesion molecule (1CAM-1) distinct from LFA-I. J. Immunol. 137, 1270-1274.
26. Jalkanen, S. T., Bargatze, R. F., Herron, L. R., Butcher, E. C. (1986) A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man. Eur. J. Immunol. 16, 1195-1202.
27. Gordon, J., Ley, S. C., Melamed, M. D., English, L. S., Hughes-Jones, N. C. (1984) Immortalized B lymphocytes produce B-cell growth factor. Nature 310, 145-147.
28. Acres, R. B., Larsen, A., Gillis, S., Conlon, P. J. (1987) Production of IL-1 α and IL-1 β by clones of EBV transformed, human B cells. Mol. Immunol. 24, 479-485.
29. Aman, P., Ehlin-Henriksson, B., Klein, G. (1984) Epstein-Barr virus susceptibility of normal human B lymphocyte populations. J. Exp. Med. 159, 208-220.
30. Gires, O., Zimber-Strobl, U., Gonnella, R., Ueffing, M., Marschall, G., Zeidler, R., Pich, D., Hammerschmidt, W. (1997) Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. EMBO J. 16, 6131-6140.
31. Caldwell, R. G., Wilson, J. B., Anderson, S. J., Longnecker, R. (1998) Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity 9, 405-411.
32. Mosialos, G., Birkenbach, M., Yalmanchili, R., VanArsdale, T., Ware, C., Kieff, E. (1995) The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80, 389-399.
33. Devergne, O., Hatzivassiliou, E., Izumi, K. M., Kaye, K. M., Kleijnen, M. F., Kieff, E., Mosialos, G. (1996) Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-κB activation. Mol. Cell. Biol. 16, 7098-7108.
34. Ansieau, S., Scheffrahn, I., Mosialos, G., Brand, H., Duyster, J., Kaye, K., Harada, J., Dougall, B., Hubinger, G., Kieff, E., Herrmann, F., Leutz, A., Gruss, H. J. (1996) Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor κ B activation. Proc. Natl. Acad. Sci. USA 93, 14053-14058.
35. Uchida, J., Yasui, T., Takaoka-Shichijo, Y., Muraoka, M., Kulwichit, W., Raab-Traub, N., Kikutani, H. (1999) Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses. Science 286, 300-303.
36. Inoue, J., Ishida, T., Tsukamoto, N., Kobayashi, N., Naito, A., Azuma, S., Yamamoto, T. (2000) Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling. Exp. Cell Res. 254, 14-24.
37. Bonnefoy, J. Y., Lecoanet-Henchoz, S., Gauchat, J. F., Graber, P., Aubry, J. P., Jeannin, P., Plater-Zyberk, C. (1997) Structure and functions of CD23. Int. Rev. Immunol. 16, 113-128.
38. Hurley, E. A., Thorley-Lawson, D. A. (1988) B cell activation and the establishment of Epstein-Barr virus latency. J. Exp. Med. 168, 2059-2075.
39. Bishop, G. A., Hostager, B. S. (2001) Signaling by CD40 and its mimics in B cell activation. Immunol. Res. 24, 97-109.
40. Covey, L. R., Cleary, A. M., Yellin, M. J., Ware, R., Sullivan, G., Belko, J., Parker, M., Rothman, J., Chess, L., Lederman, S. (1994) Isolation of cDNAs encoding T-BAM, a surface glycoprotein on CD4+ T cells mediating identity with the CD40-ligand. Mol. Immunol. 31, 471-484.
41. Rabson, M., Gradoville, L., Heston, L., Miller, G. (1982) Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye. J. Virol. 44, 834-844.
42. Miller, G., Lipman, M. (1973) Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc. Natl. Acad. Sci. USA 70, 190-194.
43. Kilger, E., Kieser, A., Baumann, M., Hammerschmidt, W. (1998) Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J. 17, 1700-1709.
44. Kilger, E., Pecher, G., Schwenk, A., Hammerschmidt, W. (1999) Expression of mucin (MUC-1) from a mini-Epstein-Barr virus in immortalized B-cells to generate tumor antigen specific cytotoxic T cells. J. Gene Med. 1, 84-92.
45. Brian, A. A. (1988) Stimulation of B-cell proliferation by membrane-associated molecules from activated T cells. Proc. Natl. Acad. Sci. USA 85, 564-568.
46. Bishop, J. Y., Schattner, E. J., Friedman, S. M. (1998) CD40 ligation impedes lymphoblastoid B cell proliferation and S-phase entry. Leuk. Res. 22, 319-327.
47. Thorley-Lawson, D. A. (2001) Epstein-Barr virus: exploiting the immune system. Nat. Rev. Immunol. 1, 75-82.
48. Lam, N., Sugden, B. (2003) CD40 and its viral mimic, LMP1: similar means to different ends. Cell. Signal. 15, 9-16.
49. Dadgostar, H., Zarnegar, B., Hoffmann, A., Qin, X. F., Truong, U., Rao, G., Baltimore, D., Cheng, G. (2002) Cooperation of multiple signaling pathways in CD40-regulated gene expression in B lymphocytes. Proc. Natl. Acad. Sci. USA 99, 1497-1502.
50. Dirmeier, U., Hoffmann, R., Kilger, E., Schultheiss, U., Briseno, C., Gires, O., Kieser, A., Eick, D., Sugden, B., Hammerschmidt, W. (2005) Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis. Oncogene 24, 1711-1717.
51. Pullen, S. S., Labadia, M. E., Ingraham, R. H., McWhirter, S. M., Everdeen, D. S., Alber, T., Crute, J. J., Kehry, M. R. (1999) High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization. Biochemistry 38, 10168-10177.
52. Sandberg, M., Hammerschmidt, W., Sugden, B. (1997) Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3. J. Virol. 71, 4649-4656.
53. Brown, K. D., Hostager, B. S., Bishop, G. A. (2001) Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1). J. Exp. Med. 193, 943-954.
54. Busch, L. K., Bishop, G. A. (2001) Multiple carboxyl-terminal regions of the EBV oncoprotein, latent membrane protein 1, cooperatively regulate signaling to B lymphocytes via TNF receptor-associated factor (TRAF)-dependent and TRAF-independent mechanisms. J. Immunol. 167, 5805-5813.
55. Stunz, L. L., Busch, L. K., Munroe, M. E., Sigmund, C. D., Tygrett, L. T., Waldschmidt, T. J., Bishop, G. A. (2004) Expression of the cytoplasmic tail of LMP1 in mice induces hyperactivation of B lymphocytes and disordered lymphoid architecture. Immunity 21, 255-266.
56. Brown, K. D., Hostager, B. S., Bishop, G. A. (2002) Regulation of TRAF2 signaling by self-induced degradation. J. Biol. Chem. 277, 19433-19438.
57. Kaykas, A., Worringer, K., Sugden, B. (2001) CD40 and LMP-1 both signal from lipid rafts but LMP-1 assembles a distinct, more efficient signaling complex. EMBO J. 20, 2641-2654.
58. Kaykas, A., Worringer, K., Sugden, B. (2002) LMP-1's transmembrane domains encode multiple functions required for LMP-1's efficient signaling. J. Virol. 76, 11551-11560.
59. Alfieri, C., Birkenbach, M., Kieff, E. (1991) Early events in Epstein-Barr virus infection of human B lymphocytes. Virology 181, 595-608.
60. Allday, M. J., Crawford, D. H. (1988) Role of epithelium in EBV persistence and pathogenesis of B-cell tumors. Lancet 1, 855-857.
61. Allday, M. J., Crawford, D. H., Griffin, B. E. (1988) Prediction and demonstration of a novel Epstein-Barr virus nuclear antigen. Nucleic Acids Res. 16, 4353-4367.
62. Mann, K. P., Staunton, D., Thorley-Lawson, D. A. (1985) Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells. J. Virol. 55, 710-720.
63. Rooney, C. M., Rowe, D. T., Ragot, T., Farrell, P. J. (1989) The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle. J. Virol. 63, 3109-3116.
64. Fahraeus, R., Jansson, A., Ricksten, A., Sjoblom, A., Rymo, L. (1990) Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element. Proc. Natl. Acad. Sci. USA 87, 7390-7394.
65. Fahraeus, R., Jansson, A., Sjoblom, A., Nilsson, T., Klein, G., Rymo, L. (1993) Cell phenotype-dependent control of Epstein-Barr virus latent membrane protein 1 gene regulatory sequences. Virology 195, 71-80.
66. Wang, F., Gregory, C., Sample, C., Rowe, M., Liebowitz, D., Murray, R., Rickinson, A., Kieff, E. (1990) Epstein-Barr virus lalent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J. Virol. 64, 2309-2318.
67. Dirmeier, U., Neuhierl, B., Kilger, E., Reisbach, G., Sandberg, M. L., Hammerschmidt, W. (2003) Latent membrane protein I is critical for efficient growth transformation of human B cells by Epstein-Barr virus. Cancer Res. 63, 2982-2989.